Clinical Trials Directory

Trials / Completed

CompletedNCT06327204

Efficacy of Different Low Level Laser Therapy Sessions

Efficacy of Different Low Level Laser Therapy Sessions in Management of Masseter Muscle Trigger Points

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
October 6 University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Myofascial pain dysfunction syndrome is one of the common causes of non-odontogenic pain in the head and neck region. It accounts for 40-60% of the adult population. Different treatment modalities had been reported to release the trigger point within the muscles of mastication in order to reduce pain and allow recovery of the function.

Detailed description

Low-level laser therapy has been a research focus in past few years as it provides effective and conservative treatment modality with minimal patient discomfort. LLLT promotes the release of endogenous opioids, enhance tissue repair and cellular respiration, increase vasodilatation and pain relief Recent systematic review and meta-analysis had reported that the available evidence didn't allow clinicians to draw firm conclusions on effective dosage. This study aimed to investigate the effect of different LLLT sessions' number on pain, maximum mouth opening and quality of life in patients with masseter muscle trigger points.

Conditions

Interventions

TypeNameDescription
DEVICE940-nm diode laser / one sessionlaser therapy using a 940-nm diode laser / one session per week
DEVICE940-nm diode laser / two sessionlaser therapy using a 940-nm diode laser / two session per week
DEVICE940-nm diode laser/ three sessionlaser therapy using a 940-nm diode laser / three session per week

Timeline

Start date
2023-03-01
Primary completion
2023-10-01
Completion
2023-12-01
First posted
2024-03-25
Last updated
2024-03-25

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06327204. Inclusion in this directory is not an endorsement.